Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | TAS1R3 | Q7RTX0 | 5/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | TP53 | P04637 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 4/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MMP13 | P45452 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6964463 | 0.88 | MMP13 (0.43) | MAPTTP53LMNAPOLBMMP13 | |
| SCHEMBL6964984 | 0.84 | MMP13 (0.39) | MAPTTP53THRBMMP13 | |
| SCHEMBL6970413 | 0.81 | BCHE (0.47) | KDM4EMAPTPKM | |
| SCHEMBL6977156 | 0.80 | GPR119 (0.40) | MMP13 | |
| SCHEMBL7951214 | 0.79 | TGFBR1 (0.44) | KDM4EMMP13PKM | |
| SCHEMBL6976765 | 0.79 | MYC (0.39) | KDM4EMMP13PKM | |
| SCHEMBL6963135 | 0.79 | STS (0.48) | KDM4EMAPTTP53LMNATHRB | |
| SCHEMBL6964258 | 0.79 | MMP13 (0.50) | KDM4ELMNAMMP13PKM | |
| SCHEMBL6976930 | 0.78 | TGFBR1 (0.45) | MAPTMMP13 | |
| SCHEMBL6964185 | 0.78 | GPR119 (0.48) | MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6333338-B1 | ANTICOAGULANTS, CARDIOVASCULAR DISORDERS | LABORATOIRE L. LAFON (FR) | 2001-12-25 | — | — | US | disclosed |